Advertisement
Screener

Beyond Air, Inc. (XAIR) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Beyond Air, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Beyond Air, Inc. (XAIR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 387.63 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13

  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 387.63K shares, a 93.59% increase year-over-year.
  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 200.22K shares, a 82.88% decline year-over-year.
  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 1.17M shares, a 88.66% decline year-over-year.
  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 10.32M shares, a 49.11% increase year-over-year.
  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 7.75M shares, a 93.03% increase from fiscal 2025.
  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.01M shares, a 82.87% decline from fiscal 2024.
  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 23.42M shares, a 139.92% increase from fiscal 2023.
  • Beyond Air, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 9.76M shares, a 41.07% increase from fiscal 2022.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-30387.63K shares
10-Q · filed 2026-08-13
2026-03-317.75M shares
10-K · filed 2026-06-26
2025-12-313.74M shares
10-Q · filed 2026-02-13
2025-09-303.28M shares
10-Q · filed 2025-11-10
2025-06-30200.22K shares
10-Q · filed 2026-08-13
4.00M shares
10-Q · filed 2025-08-12
2025-03-314.01M shares
10-K · filed 2026-06-26
80.25M shares
10-K · filed 2025-06-20
2024-12-314.56M shares
10-Q · filed 2026-02-13
91.15M shares
10-Q · filed 2025-02-10
2024-09-304.69M shares
10-Q · filed 2025-11-10
93.75M shares
10-Q · filed 2024-11-12
2024-06-301.17M shares
10-Q · filed 2025-08-12
23.39M shares
10-Q · filed 2024-08-06
2024-03-3123.42M shares
10-K · filed 2025-06-20
2023-12-319.81M shares
10-Q · filed 2025-02-10
2023-09-3010.31M shares
10-Q · filed 2024-11-12
2023-06-3010.32M shares
10-Q · filed 2024-08-06
2023-03-319.76M shares
10-K · filed 2024-06-24
2022-12-316.88M shares
10-Q · filed 2024-02-12
2022-09-306.99M shares
10-Q · filed 2023-11-13
2022-06-306.92M shares
10-Q · filed 2023-08-10
2022-03-316.92M shares
10-K · filed 2023-06-22
2021-12-316.93M shares
10-Q · filed 2023-02-10
2021-09-307.83M shares
10-Q · filed 2022-11-08
2021-06-308.20M shares
10-Q · filed 2022-08-11
2021-03-318.18M shares
10-K · filed 2022-06-29
8.17M shares
10-K · filed 2021-06-10
2020-12-318.71M shares
10-Q · filed 2022-02-10
2020-09-308.92M shares
10-Q · filed 2021-11-12
2020-06-308.92M shares
10-Q · filed 2021-08-10
2020-03-318.87M shares
10-K · filed 2021-06-10
2019-12-319.08M shares
10-Q · filed 2020-02-07
9.08M shares
10-Q · filed 2021-02-09
2019-09-308.83M shares
10-Q · filed 2019-11-06
8.83M shares
10-Q · filed 2020-11-12
2019-06-308.82M shares
10-Q · filed 2020-08-06
2019-03-318.86M shares
10-K · filed 2020-06-23
2018-12-317.97M shares
10-Q · filed 2020-02-07
7.97M shares
10-Q · filed 2020-02-07
7.99M shares
10-Q · filed 2019-02-14
2018-09-307.54M shares
10-Q · filed 2019-11-06
7.54M shares
10-Q · filed 2019-11-06
2018-03-316.66M shares
10-K · filed 2019-06-28
54.15K shares
10-KT · filed 2018-06-15
2017-12-314.61M shares
10-Q · filed 2019-02-14
4.61M shares
10-Q · filed 2019-02-14
4.39M shares
10-K · filed 2019-06-28
2017-09-30880.51K shares
10-Q · filed 2018-11-14
880.51K shares
10-Q · filed 2018-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B